https://www.biospace.com/article/j-and-j-and-barda-s-blue-knight-pick-7-startups-to-battle-covid-19-and-beyond/

Blue Knight is a program created in partnership with Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA). The idea is to support companies that anticipate “potential health security threats, activating the global innovation community, and amplifying scientific and technological advances with the aim to prepare for and respond to our rapidly evolving global health environment.”

In short, given the world’s current COVID-19 pandemic, Blue Knight is...

Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services to form Blue Knight. This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases.

Find out more about BARDA and its mission at www.PHE.gov/BARDA.

https://www.fiercebiotech.com/biotech/j-j-barda-pick-7-startups-to-back-fight-against-covid-19-and-beyond

As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson & Johnson and the U.S. Biomedical Advanced Research and Development Authority (BARDA) are teaming up once again to answer that.

Through a joint effort dubbed Blue Knight, the duo aims to boost innovation and “amplify” scientific and technological advancements to...